Table 1.
Cohort Demographics.
| Total Patients | 139 | |
|---|---|---|
| Median age (years) | 66 | |
| Males | 105 | |
| Females | 34 | |
| Exclusions | ||
| Metastatic disease (non-BC) | 3 | |
| Failed inclusion criteria | ||
| Initially > pT1 | 2 | |
| No prior BC | 1 | |
| Notable concurrent factors | ||
| Prior BCG treatment | 50 | 36% |
| Hematuria | 11 | 8% |
| Smokers | 53 | 38% |
| Initial T-stage | ||
| pTis | 5 | 4% |
| pTa | 111 | 80% |
| pT1 | 20 | 14% |
| Initial grading | ||
| High-grade | 63 | 45% |
| Low-grade | 62 | 44% |
| Unknown | 11 | 8% |
| EORTC risk classification | ||
| Very-high | 6 | 4% |
| High | 41 | 29% |
| Intermediate | 31 | 22% |
| Low | 58 | 42% |
WLCs: white light cystoscopies; XBCM: Xpert© bladder cancer monitor; NBI: narrow. Band imaging©; TURBTs: trans-urethral resection of bladder tumors.